Patients scheduled to receive cisplatin ( @ mg/m @ ) were administered a single IV dose of fosaprepitant dimeglumine ( @ mg ) on day @ or a @-day dosing regimen of oral aprepitant ( day @:@ mg , days @ and @:@ mg ) with standard doses of ondansetron and dexamethasone .